Pfizer and 3SBio conclude licensing deal for SSGJ-707
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the development, production…
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the development, production…
GSK has secured approval in the European Union (EU) for Blenrep combinations to treat adults with relapsed or refractory multiple…
Kling Bio has entered a partnership and licence option agreement with Sanofi to discover neutralising antibodies and epitopes. The partnership…
The European Commission (EC) has approved the Johnson & Johnson company Janssen-Cilag International’s new indication for Darzalex Faspro (daratumumab) subcutaneous…
AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D). The…
Sanofi has signed an agreement to acquire UK-based biotechnology company Vicebio’s share capital for $1.15bn upfront, to expand its vaccine…
Johnson & Johnson (J&J) has submitted a new drug application (NDA) seeking approval from the US Food and Drug Administration…
Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North…
Sanofi has completed its acquisition of Blueprint Medicines, enhancing its portfolio with a commercialised therapy and the expertise of a…
Fangzhou has signed a memorandum of understanding (MoU) with Novo Nordisk to collaborate on the management of serious chronic diseases…